PROKIDNEY CORP. (PROK)

↓ Download CSV

CIK 0001850270 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated E9
  • Fiscal year ends Dec 31

In fiscal 2025, PROKIDNEY CORP. reported revenue of $893.0K, up 1075.0% from the prior year. The company ran a net loss, with a net margin of -16977.8%. It held $335.57M in total assets against $34.78M in total liabilities.

Key ratios (FY2025)

-18477.8%
Operating margin
-16977.8%
Net margin
+1075.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$893.0K$76.0K$0$0
Operating Income-$165.01M-$183.68M-$151.52M-$153.01M-$55.11M-$27.02M
Net Income-$151.61M-$163.34M-$135.45M-$148.13M-$55.15M-$26.75M
EPS (Diluted)$-0.23
Total Assets$335.57M$441.07M$420.55M$518.00M$40.30M
Total Liabilities$34.78M$39.44M$29.22M$13.06M$13.38M
Shareholders' Equity-$1.01B-$994.95M-$1.10B-$1.10B$26.92M$9.86M$15.88M
Cash & Equivalents$108.54M$99.12M$60.65M$490.25M$20.56M
Operating Cash Flow-$120.12M-$126.35M-$90.07M-$77.09M-$50.30M-$25.18M
Capital Expenditures$15.20M$29.51M$34.20M$1.85M$5.19M$5.46M
Shares Outstanding61.54M